Jenny Kobin | Investor Relations |
George Lasezkay | President and Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer and Chief Development Officer |
Charles Deignan | Chief Financial Officer |
Zegbeh Jallah | ROTH Capital Partners |
Jonathan Wolleben | JMP Securities |
Yi Chen | H.C. Wainwright |
Serge Belanger | Needham |
Julian Harrison | BTIG |
Good day and thank you for standing by. Welcome to the Clearside Biomedical First Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-Answer session. [Operator Instructions] Now, it is my pleasure to hand the conference over to your first speaker today, Jenny Kobin, Clearside Investor Relations.